ADIL
UBS Group’s Adial Pharmaceuticals ADIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74K | Sell |
12,395
-35,350
| -74% | -$10.7K | ﹤0.01% | 8001 |
|
|
2025
Q1 | $30.3K | Buy |
47,745
+26,727
| +127% | +$16.9K | ﹤0.01% | 6641 |
|
|
2024
Q4 | $21.2K | Buy |
21,018
+16,614
| +377% | +$16.8K | ﹤0.01% | 6598 |
|
|
2024
Q3 | $4.4K | Sell |
4,404
-79,201
| -95% | -$79.1K | ﹤0.01% | 6935 |
|
|
2024
Q2 | $96.1K | Buy |
83,605
+77,879
| +1,360% | +$89.6K | ﹤0.01% | 5054 |
|
|
2024
Q1 | $7.62K | Buy |
5,726
+2,104
| +58% | +$2.8K | ﹤0.01% | 6203 |
|
|
2023
Q4 | $6.74K | Buy |
3,622
+3,076
| +563% | +$5.72K | ﹤0.01% | 6466 |
|
|
2023
Q3 | $1.52K | Buy |
+546
| New | +$1.52K | ﹤0.01% | 6766 |
|
|
2023
Q2 | – | Sell |
-10,630
| Closed | -$3.72K | – | 7740 |
|
|
2023
Q1 | $3.72K | Sell |
10,630
-11,425
| -52% | -$4K | ﹤0.01% | 7185 |
|
|
2022
Q4 | $4.85K | Sell |
22,055
-13,462
| -38% | -$2.96K | ﹤0.01% | 8070 |
|
|
2022
Q3 | $12K | Buy |
+35,517
| New | +$12K | ﹤0.01% | 7035 |
|
|
2022
Q2 | – | Sell |
-6,840
| Closed | -$14K | – | 9193 |
|
|
2022
Q1 | $14K | Buy |
6,840
+3,216
| +89% | +$6.58K | ﹤0.01% | 6870 |
|
|
2021
Q4 | $10K | Sell |
3,624
-766
| -17% | -$2.11K | ﹤0.01% | 7631 |
|
|
2021
Q3 | $19K | Buy |
+4,390
| New | +$19K | ﹤0.01% | 6057 |
|
|
2021
Q2 | – | Sell |
-4,447
| Closed | -$11K | – | 8222 |
|
|
2021
Q1 | $11K | Sell |
4,447
-6,672
| -60% | -$16.5K | ﹤0.01% | 6816 |
|
|
2020
Q4 | $19K | Buy |
11,119
+9,798
| +742% | +$16.7K | ﹤0.01% | 5960 |
|
|
2020
Q3 | $3K | Buy |
+1,321
| New | +$3K | ﹤0.01% | 6618 |
|
|
2019
Q3 | – | Sell |
-1,692
| Closed | -$3K | – | 6976 |
|
|
2019
Q2 | $3K | Sell |
1,692
-2,099
| -55% | -$3.72K | ﹤0.01% | 6637 |
|
|
2019
Q1 | $13K | Buy |
3,791
+1,068
| +39% | +$3.66K | ﹤0.01% | 5791 |
|
|
2018
Q4 | $14K | Buy |
2,723
+2,165
| +388% | +$11.1K | ﹤0.01% | 6100 |
|
|
2018
Q3 | $2K | Buy |
+558
| New | +$2K | ﹤0.01% | 6790 |
|